Similar articles

• Sodium valproate and the liver.

  [No authors listed] [No authors listed] Lancet. 1980 Nov 22;2(8204):1119-20. Lancet. 1980. PMID: 6107730 No abstract available.
• Valproate toxicity: risk-screening strategies.

  Willmore LJ, Triggs WJ, Pellock JM. Willmore LJ, et al. J Child Neurol. 1991 Jan;6(1):3-6. doi: 10.1177/088307389100600101. J Child Neurol. 1991. PMID: 2002198 Review. No abstract available.
• Acute hepatic failure associated with the use of sodium valproate.

  Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, Kearns GL, Stull JD, Bove KE. Suchy FJ, et al. N Engl J Med. 1979 Apr 26;300(17):962-6. doi: 10.1056/NEJM197904263001706. N Engl J Med. 1979. PMID: 372803 No abstract available.
• Fatal liver failure in children on valproate.

  Scheffner D. Scheffner D. Lancet. 1986 Aug 30;2(8505):511. doi: 10.1016/s0140-6736(86)90376-4. Lancet. 1986. PMID: 2875255 No abstract available.
• Hepatotoxicity to sodium valproate: a review.

  Powell-Jackson PR, Tredger JM, Williams R. Powell-Jackson PR, et al. Gut. 1984 Jun;25(6):673-81. doi: 10.1136/gut.25.6.673. Gut. 1984. PMID: 6428980 Free PMC article. Review. No abstract available.